Utilizing portable electroencephalography to screen for pathology of Alzheimer's disease: a methodological advancement in diagnosis of neurodegenerative diseases.

Alzheimer’s disease EEG amyloid beta deep learning dementia

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2024
Historique:
received: 27 02 2024
accepted: 29 04 2024
medline: 10 6 2024
pubmed: 10 6 2024
entrez: 10 6 2024
Statut: epublish

Résumé

The current biomarker-supported diagnosis of Alzheimer's disease (AD) is hindered by invasiveness and cost issues. This study aimed to address these challenges by utilizing portable electroencephalography (EEG). We propose a novel, non-invasive, and cost-effective method for identifying AD, using a sample of patients with biomarker-verified AD, to facilitate early and accessible disease screening. This study included 35 patients with biomarker-verified AD, confirmed via cerebrospinal fluid sampling, and 35 age- and sex-balanced healthy volunteers (HVs). All participants underwent portable EEG recordings, focusing on 2-minute resting-state EEG epochs with closed eyes state. EEG recordings were transformed into scalogram images, which were analyzed using "vision Transformer(ViT)," a cutting-edge deep learning model, to differentiate patients from HVs. The application of ViT to the scalogram images derived from portable EEG data demonstrated a significant capability to distinguish between patients with biomarker-verified AD and HVs. The method achieved an accuracy of 73%, with an area under the receiver operating characteristic curve of 0.80, indicating robust performance in identifying AD pathology using neurophysiological measures. Our findings highlight the potential of portable EEG combined with advanced deep learning techniques as a transformative tool for screening of biomarker-verified AD. This study not only contributes to the neurophysiological understanding of AD but also opens new avenues for the development of accessible and non-invasive diagnostic methods. The proposed approach paves the way for future clinical applications, offering a promising solution to the limitations of advanced diagnostic practices for dementia.

Sections du résumé

Background UNASSIGNED
The current biomarker-supported diagnosis of Alzheimer's disease (AD) is hindered by invasiveness and cost issues. This study aimed to address these challenges by utilizing portable electroencephalography (EEG). We propose a novel, non-invasive, and cost-effective method for identifying AD, using a sample of patients with biomarker-verified AD, to facilitate early and accessible disease screening.
Methods UNASSIGNED
This study included 35 patients with biomarker-verified AD, confirmed via cerebrospinal fluid sampling, and 35 age- and sex-balanced healthy volunteers (HVs). All participants underwent portable EEG recordings, focusing on 2-minute resting-state EEG epochs with closed eyes state. EEG recordings were transformed into scalogram images, which were analyzed using "vision Transformer(ViT)," a cutting-edge deep learning model, to differentiate patients from HVs.
Results UNASSIGNED
The application of ViT to the scalogram images derived from portable EEG data demonstrated a significant capability to distinguish between patients with biomarker-verified AD and HVs. The method achieved an accuracy of 73%, with an area under the receiver operating characteristic curve of 0.80, indicating robust performance in identifying AD pathology using neurophysiological measures.
Conclusions UNASSIGNED
Our findings highlight the potential of portable EEG combined with advanced deep learning techniques as a transformative tool for screening of biomarker-verified AD. This study not only contributes to the neurophysiological understanding of AD but also opens new avenues for the development of accessible and non-invasive diagnostic methods. The proposed approach paves the way for future clinical applications, offering a promising solution to the limitations of advanced diagnostic practices for dementia.

Identifiants

pubmed: 38855641
doi: 10.3389/fpsyt.2024.1392158
pmc: PMC11157607
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1392158

Informations de copyright

Copyright © 2024 Hata, Miyazaki, Mori, Yoshiyama, Akamine, Kanemoto, Gotoh, Omori, Hirashima, Satake, Suehiro, Takahashi and Ikeda.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Masahiro Hata (M)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Yuki Miyazaki (Y)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Kohji Mori (K)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Kenji Yoshiyama (K)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Shoshin Akamine (S)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Hideki Kanemoto (H)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Shiho Gotoh (S)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Hisaki Omori (H)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Psychiatry, Esaka Hospital, Osaka, Japan.

Atsuya Hirashima (A)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Psychiatry, Esaka Hospital, Osaka, Japan.

Yuto Satake (Y)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Takashi Suehiro (T)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Shun Takahashi (S)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
Department of Occupational Therapy, Graduate School of Rehabilitation Science, Osaka Metropolitan University, Osaka, Japan.
Clinical Research and Education Center, Asakayama General Hospital, Osaka, Japan.
Department of Neuropsychiatry, Wakayama Medical University, Wakayama, Japan.

Manabu Ikeda (M)

Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.

Classifications MeSH